STK33 Antibody (monoclonal) (M09)
Mouse monoclonal antibody raised against a full length recombinant STK33.
|Application ||WB, IF, IP|
|Reactivity||Human, Mouse, Rat|
|Calculated MW||57831 Da|
|Other Names||Serine/threonine-protein kinase 33, STK33|
|Target/Specificity||STK33 (AAH31231, 1 a.a. ~ 514 a.a) full-length recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.|
|Format||Clear, colorless solution in phosphate buffered saline, pH 7.2 .|
|Storage||Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.|
|Precautions||STK33 Antibody (monoclonal) (M09) is for research use only and not for use in diagnostic or therapeutic procedures.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
1.STK33 Kinase Activity is Non-Essential in KRAS-Dependent Cancer Cells.Babij C, Zhang Y, Kurzeja RJ, Munzli A, Shehabeldin A, Fernando M, Quon K, Kassner PD, Ruefli-Brasse AA, Watson VJ, Fajardo F, Jackson A, Zondlo J, Sun Y, Ellison AR, Plewa CA, San Miguel T, Robinson J, McCarter J, Schwandner R, Judd T, Carnahan J, Dussault I.Cancer Res. 2011 Jul 8. [Epub ahead of print]2.Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells.Scholl C, Frohling S, Dunn IF, Schinzel AC, Barbie DA, Kim SY, Silver SJ, Tamayo P, Wadlow RC, Ramaswamy S, Dohner K, Bullinger L, Sandy P, Boehm JS, Root DE, Jacks T, Hahn WC, Gilliland DG.Cell. 2009 May 29;137(5):821-34.
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at firstname.lastname@example.org.